Other languages Johnson & Johnson Xetra

Equities

Market Closed - Xetra Other stock markets 11:35:51 2024-06-12 am EDT			5-day change	1st Jan Change
134.6 ^EUR	-1.26%		-0.53%	-5.04%

Jun. 12	Transcript : Johnson & Johnson Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 02:00 PM
Jun. 12	Cancer victims ask court to block J&J talc bankruptcy	RE

Cancer victims ask court to block J&J talc bankruptcy	Jun. 12
Sector Update: Health Care Stocks Softer Late Afternoon	Jun. 11
Sector Update: Health Care	Jun. 11
Johnson & Johnson to Pay $700 Million in Talc Case Settlement With 43 State Prosecutors	Jun. 11
RTW Biotech portfolio company to sell subsidiary for USD1.25 billion	Jun. 11
Top law firms in US opioid lawsuits to get hundreds of millions in fees	Jun. 07
J&J-backed Rapport Therapeutics shares debut nearly 6% higher	Jun. 07
J&J : la FDA approuve VELYS dans l'arthroplastie du genou	Jun. 07
AbbVie's tight grip on Humira market raises concerns about biosimilars	Jun. 07
J&J-backed Rapport Therapeutics raises $136 mln in US IPO	Jun. 06
Borsa di Italia: Verso l'infinito e oltre	Jun. 06
Bolsa de Madrid: Hasta el infinito y más allá	Jun. 06
J&J : sollicite la FDA une indiation élargie du Prezcobix	Jun. 05
J&J : essai concluant pour Carvykti dans le myélome multiple	Jun. 04
J&J : essai prometteur pour Tecvayli dans le myélome multiple	Jun. 04
Johnson & Johnson Ordered to Pay $260 Million In Talc Powder Case	Jun. 04
Borsa di Italia: Mai contenti!	Jun. 04
J&J must pay $260 million in latest talc trial, Oregon jury says	Jun. 03
Legend Biotech Says Phase 2 Trial of Carvykti to Treat Multiple Myeloma Showed 'Deep, Durable' Responses	Jun. 03
Johnson & Johnson Announces Results from a Subgroup Analysis of the Phase 3 CARTITUDE-4 Study	Jun. 03

No results for this search

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST